Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated Vaccines

NCT05952505 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

540

Enrollment

OTHER

Sponsor class

Conditions

SARS-CoV-2 Infection
Varicella
Measles
Mumps
Rubella

Interventions

BIOLOGICAL: Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
BIOLOGICAL: Inactivated SARS-CoV-2 vaccine coadministered with MMR
BIOLOGICAL: Inactivated SARS-CoV-2 vaccine administered alone

Sponsor

Shanghai Municipal Center for Disease Control and Prevention

Collaborators

[object Object]